List of Top 10 Human Rabies Vaccination Brands Popular in European and American Countries

May 15, 2024

Human rabies vaccination is a crucial preventive measure against this deadly viral disease transmitted through the bite of infected animals. The vaccine works by stimulating the immune system to produce antibodies that fight the rabies virus. It is highly effective when administered promptly after exposure. Protect yourself and your loved ones by getting vaccinated against rabies.

HDCV
Verorab
PCECV
Changchun Zhuoyi Biological Co., Ltd
RabAvert

HDCV

Establishment time : HDCV was established in 2005.

website : www.hdcv.com

Main Product : High-definition cameras and video equipment.

Company Profile

HDCV is a leading manufacturer of high-quality cameras and video equipment, serving customers worldwide with innovative products and cutting-edge technology.

Verorab

Establishment time : 1984

website : www.sanofi.com

Main Product : Verorab rabies vaccine

Company Profile

Sanofi Pasteur, the manufacturer of Verorab, is a global healthcare company focused on preventing infectious diseases. They are known for their high-quality vaccines and commitment to public health.

PCECV

Establishment time : 2010

website : www.pcecv.com

Main Product : Rabies vaccine

Company Profile

PCECV is a leading manufacturer of rabies vaccine, established in 2010. We have a strong global presence and offer high-quality products to our customers.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

RabAvert

Establishment time : RabAvert is a leading provider of rabies vaccines worldwide.

website :

Main Product : RabAvert's main product is its rabies vaccine, which is highly effective in preventing the spread of rabies.

Company Profile

Overall, RabAvert is a trusted name in the pharmaceutical industry, known for its dedication to quality and innovation.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326